ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma

Qin, Shijie; Xu, Jieyun; Yi, Yunmeng; Jiang, Sizhu; Jin, Ping*; Xia, Xinyi*; Ma, Fei*南方医科大学; 南京大学; 1
Frontiers in Oncology2021-7-1DOI: 10.3389/fonc.2021.691115
6被引11阅读
引用收藏
分享

摘要

Many dysregulated microRNAs (miRNAs) have been suggested to serve as oncogenes or tumor suppressors to act as diagnostic and prognostic factors for HCC patients. However, the dysregulated mechanisms of miRNAs in HCC remain largely unknown. Herein, we firstly identify 114 disordered mature miRNAs in HCC, 93 of them are caused by dysregulated transcription factors, and 10 of them are driven by the DNA methylation of their promoter regions. Secondly, we find that seven up-regulated miRNAs (miR-9-5p, miR-452-5p, miR-452-3p, miR-1180-3p, miR-4746-5p, miR-3677-3 and miR-4661-5p) can promote tumorigenesis via inhibiting multiple tumor suppressor genes participated in metabolism, which may act as oncogenes, and seven down-regulated miRNAs (miR-99-5p, miR-5589-5p, miR-5589-3p, miR-139-5p, miR-139-3p, miR-101-3p and miR-125b-5p) can suppress abnormal cell proliferation via suppressing a number of oncogenes involved in cancer-related pathways, which may serve as tumor suppressors. Thirdly, our findings reveal a mechanism that transcription factor and miRNA interplay can form various regulatory loops to synergistically control the occurrence and development of HCC. Finally, our results demonstrate that this key transcription factor FOXO1 can activate a certain number of tumor suppressor miRNAs to improve the survival of HCC patients, suggesting FOXO1 as an effective therapeutic target for HCC patients. Overall, our study not only reveals the dysregulated mechanisms of miRNAs in HCC, but provides several novel prognostic biomarkers and potential therapeutic targets for HCC patients.

学科与关键词

关键词
hepatocellular carcinoma (HCC)miRNAmethylationprognosistranscription factor
相关
加载中…
  • Construction of a potential microRNA, transcription factor and mRNA regulatory network in hepatocellular carcinoma
    Li, Ning; Jiang, Shaotao; Shi, Jiewei; Fu, Rongdang; Wu, Huijie; Lu, Minqiang*Translational Cancer Research, 2020, 9(9): 5528-+.被引 3
  • Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
    Zhen, Limin; Ning, Gang; Wu, Lina; Zheng, Yongyuan; Yang, Fangji; Chen, Tongtong; Xu, Wenxiong; Liu, Ying; Xie, Chan*; Peng, Liang*Bioscience Reports, 2020, 40: BSR20192593.被引 6
  • The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2
    Zheng F; Liao Y J; Cai M Y; Liu Y H; Liu T H; Chen S P; Bian X W; Guan X Y; Lin M C; Zeng Y X; Kung H F; Xie D*Gut, 2012, 61(2): 278-289.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2021-07-01
卷期
第 11 卷
页码
691115
DOI
10.3389/fonc.2021.691115
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Natural Science Foundation of Jiangsu Province [BK20191368]; Key Research AMP; Development Program of Jiangsu Province [BE2018713]; Jiangsu Provincial Association for Maternal and Child Health Studies Commissioned Research Project Funding [JSFY202005]; Open subject of Jiangsu Population Society [JSPA2019017, JSPA2019020]; National Population Commission Open subject [YJJC201802]; Priority Academic Program Development of Jiangsu Higher Education Institutions

作者

  • Q

    Qin, Shijie (第一作者)

    nanjing normal univ · 1 · nanjing univ · southern med univ

  • X

    Xu, Jieyun

    nanjing normal univ

查看全部 7 位作者收起作者
  • Y

    Yi, Yunmeng

    nanjing normal univ

  • J

    Jiang, Sizhu

  • J

    Jin, Ping (通讯)

    nanjing normal univ

  • X

    Xia, Xinyi (通讯)

    1 · nanjing univ · southern med univ

  • M

    Ma, Fei (通讯)

    nanjing normal univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417